Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells

Biochem Biophys Res Commun. 2007 Apr 20;355(4):956-62. doi: 10.1016/j.bbrc.2007.02.054. Epub 2007 Feb 21.

Abstract

Mesenchymal stromal cells (MSCs) have been shown to have an immunosuppressive effect. Previously, we demonstrated that nitric oxide (NO) is one of the immunomodulatory mediators of MSCs. We herein show that primary mouse bone marrow MSCs and three cell lines that mimic MSCs suppress both differentiation and proliferation in Th1 condition, whereas the suppression in Th2 condition is mild. NO production is inversely correlated with T cell proliferation in Th1 and Th2 conditions. NO is highly induced in Th1 and minimally induced in Th2. Moreover, an inhibitor of NO synthase restores both proliferation and interferon-gamma (IFN-gamma) production in Th1 condition. Furthermore, an anti-IFN-gamma antibody strongly inhibits NO production and an inhibitor of NF-kappaB reduces the level of induction of inducible NO synthase (iNOS) in MSCs. Taken together, our results suggest that NO plays a significant role in the modification of Th1 and Th2 differentiation by MSCs, and that both IFN-gamma and NF-kappaB are critical for NO production by MSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacology
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism*
  • Mice
  • NF-kappa B / metabolism*
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Th1 Cells / cytology
  • Th1 Cells / metabolism
  • Th2 Cells / cytology
  • Th2 Cells / metabolism

Substances

  • NF-kappa B
  • Nitric Oxide
  • Interferon-gamma
  • Nitric Oxide Synthase